NOX2 dampens TLR7 to protect the kidneys in SLE

Monica Wang
DOI: https://doi.org/10.1038/s41581-024-00890-6
IF: 42.439
2024-08-30
Nature Reviews Nephrology
Abstract:Lupus nephritis (LN) is a common clinical complication in patients with systemic lupus erythematosus (SLE). A report by Mark J. Shlomchik and colleagues reveals an interplay between NADPH oxidase 2 (NOX2) and Toll-like receptor 7 (TLR7) in B cells that can modulate SLE severity, including its kidney manifestations. The researchers propose that this protection might result from NOX2-mediated inhibition of TLR7 activity. When stimulated with a TLR7 agonist, Cybb -KO B cells had enhanced nuclear factor-κB activation compared with wild-type B cells, and in global Cybb -KO lupus mice, deleting Tlr7 in B cells had a protective effect.
urology & nephrology
What problem does this paper attempt to address?